21) Inspired by nature´s design: From Biomimetic enterobactin analogues  and fluorescent imaging tools, 10.06.2021, Colloquium of Organic Chemistry and Biochemistry, Department of Chemistry, TU München.

 

20) Inspired by nature´s design: Biomimetic enterobactin analogues for antimicrobial drug conjugates and fluorescent imaging tools, 19.03.2021, Biosolve IT webinar.

 

19) Artificial enterobactin analogues as extracellular-targeted carrier molecules for antimicrobial drug conjugates, 16.03.2021, Chemiedozententagung 2021, virtual conference.

 

18) Development of antimicrobial siderophore-drug conjugates – From artificial siderophores, novel payloads, bioresponsive linkers and smart fluorescent dyes, 03.12.2020, Georg-August Universität Göttingen, Institut für Organische und Biomolekulare Chemie/MBExC Multiscale Bioimaging- Cluster of Excellence.

 

13) Neue Wege gegen Gram-negative Pathogene - Antimikrobielle Wirkstoff-Konjugate auf Basis von artifiziellen Enterobactin-Analoga, 13.11.2020, Braunschweigische Wissenschaftliche Gesellschaft (BWG) Klassensitzung der Klasse für Mathematik und Naturwissenschaften, Braunschweig. 

 

12) Inspired by nature´s design: Artificial enterobactin analogues for antimicrobial drug conjugates and smart fluorescence dyes, Symposium of the DFG Collaborative Research Centre TR-SFB 261, 10.12.2019, Kekulé-Institute of Organic Chemistry and Biochemistry, Rheinischen Friedrich-Wilhelms-Universität Bonn, Bonn.

 

11) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 28. Nachwuchswissenschaftler-Symposium Bioorganische Chemie, 24.09.2019, Universität Duisburg-Essen, Essen.

 

10) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 19.09.2019, BMWZ Symposium, BMWZ/Leibniz Universität Hannover, Hannover.

 

9) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 26.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

8) Development of natural product-based antibacterials targeting the sliding clamp DnaN (NaPAnti) - Development of novel bifunctional GM hybrid antimicrobials and conjugates, Kick-Off Meeting NaPAnti-BMBF-Project, 25.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

7) Development of a universal synthetic de novo access to all cytochalasan sub-classes and novel cytochalasan derivatives - A comprehensive, combinatorical approach for the exploration of the target selectivity of the cytochalasans, Initiationsmeeting DFG Researcher group Application, 12.03.2019, BMWZ, Leibnitz Universität Hannover.

 

6) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 31. Irseer Naturstoff-tagung, 20.02.2019, Kloster Irsee.

 

5) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Advances in Chemical Biology 2018, Dechema, 30.01.2018, Frankfurt am Main.

 

4) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Bundesfachtagung (BuFaTa) Chemie, 03.11.2017. Braunschweig.

 

3) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 21. Mitgliederversammlung des Fördervereins der Freunde des Instituts für Organische Chemie an der Technischen Universität Braunschweig e.V., 21.10.2017, Braunschweig.

 

2) Einmal Texas und zurück – Ein Weg in die Akademie, Netzwerker-Tagung der Alexander-von-Humboldt Stiftung, 20.10.2017, Bielefeld.

 

1) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 26. Nachwuchswissenschaftler-Symposium Bioorganische Chemie, 20.09.2017, TU Berlin.